|4Jul 6, 4:44 PM ET

Calabrese Jeffrey 4

4 · AERIE PHARMACEUTICALS INC · Filed Jul 6, 2022

Insider Transaction Report

Form 4
Period: 2022-07-01
Calabrese Jeffrey
Vice President of Finance
Transactions
  • Award

    Common Stock

    2022-07-01+11,27619,295 total
  • Award

    Stock Option (right to buy)

    2022-07-01+20,77420,774 total
    Exercise: $8.36Exp: 2032-07-01Common Stock (20,774 underlying)
Footnotes (2)
  • [F1]These shares of Common Stock are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first four anniversaries of July 1, 2022.
  • [F2]This Option is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first 48 monthly anniversaries of July 1, 2022.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24

    POA DOCUMENT